Dr. Lal Pathlabs’ arm gets nod to acquire further 10% stake in APRL PathLabs

31 Jan 2023 Evaluate

Dr. Lal Pathlabs’ Wholly Owned Subsidiary--- PathLabs Unifiers (PUPL) has received approval for the acquisition of further 10% equity stake in its Subsidiary Company i.e. APRL PathLabs (APRL). Object of acquisition is to strengthen the company’s presence in the state of Gujarat, India. Cost of acquisition is around Rs 7.50 Million. Post this acquisition, total equity stake of PUPL in APRL will increase from 70% to 80%. The Board of Directors of the company in their meeting held on January 30, 2023 approved the same.

Dr. Lal Pathlabs is a provider of diagnostic and related healthcare tests and services in India.

Dr. Lal Pathlabs Share Price

2953.35 -67.15 (-2.22%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7248.75
Max Healthcare Inst 1166.60
Narayana Hrudayalay 1286.30
Aster DM Healthcare 486.85
Global Health 1098.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.